Incidence of brain metastasis in lung adenocarcinoma at initial diagnosis onthe basis of stage and genetic alterations
- Title
- Incidence of brain metastasis in lung adenocarcinoma at initial diagnosis onthe basis of stage and genetic alterations
- Author
- 이현
- Keywords
- Brain metastasis; Non-smallcelllungcarcinoma; Adenocarcinoma; Neoplasmstaging; Genetic alterations
- Issue Date
- 2019-01
- Publisher
- ELSEVIER IRELAND LTD
- Citation
- LUNG CANCER, v. 129, Page. 28-34
- Abstract
- Objective: Patients with lung adenocarcinoma (ADC) are at higher risk of the development of brain metastasis (BM), and genetic alterations are associated with BM.
Patients and methods: A total of 598 patients with lung ADC in our institution between January 2014 and December 2014 were reviewed retrospectively. We evaluated the incidence of BM by stage and genetic al-terations.
Results: Of the 598 patients, 97 (16.2%) had BM, which occurred across all stages. The incidence of BM showed a tendency to increase as the stage increased (p ˂ 0.001, trend test). Although patients with EGFR mutations had BM across all stages, those with ALK or K- mutations had BM only in stage III and IV diseases. Regardless of types of mutations, the incidence of BM showed a tendency to increase as the T or N staging increased (p ˂ 0.001 for each of EGFR, ALK, and K-RAS mutations, trend test). Whereas BM incidence showed a tendency to increase as the M staging increased in patients with EGFR-mutant lung ADC (p ˂ 0.001, trend test), there was no linear trend between M staging and ALK (p = 0.469, trend test) or K-RAS mutations (p = 0.066, trend test). After adjusting covariables, EGFR mutations were associated with BM in never-smokers (adjusted OR = 2.07, 95% CI = 1.02 – 4.34) and K-RAS mutations were risk factors for BM in males (adjusted OR = 3.86, 95% CI = 1.01–14.43).
Conclusions: BM occurred in approximately 16% of lung ADC patients, including 3% with stage I diseases. Whereas EGFR-mutant lung ADC had BM across all stages, ALK- or K-RAS-mutant lung ADC had BM only in advanced stages. EGFR mutations were risk factors for BM among never-smokers and K-RAS mutations were risk factors among males.
- URI
- https://www.sciencedirect.com/science/article/pii/S016950021830727X?via%3Dihubhttps://repository.hanyang.ac.kr/handle/20.500.11754/102856
- ISSN
- 0169-5002; 1872-8332
- DOI
- 10.1016/j.lungcan.2018.12.027
- Appears in Collections:
- COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML